The oncology community is well aware that cancer therapy is fraught with increased risk of cardiovascular disease (CVD). Of the almost 12 million cancer survivors in the United States, many are more likely to die of CVD...
Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, according to a new study. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, an abnormal physical examination or an abnormal blood test at the time of relapse, researchers say.
Patients at higher or lower risk for having their cancer recur elsewhere in the body more than 5 years after diagnosis can be differentiated by a gene expression test. The test measures the expression levels of 58 genes in estrogen receptor-positive breast cancers. These research results were presented at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
FOLFIRINOX chemotherapy plus chemoradiation helped make resection possible in locally advanced pancreatic cancer.
Digital breast tomosynthesis may be more accurate than mammography but with greater radiation exposure, additional study comparing the detection methods would be beneficial.
No significant difference in morbidity, cancer control for men treated post-prostatectomy using Intensity-modulated radiotherapy (IMRT) over conformal radiotherapy (CRT).
Initial results confirm more positive screening results, diagnostic procedures, cancer ID'd with CT versus standard chest X-rays.
Caregivers need care, too. Patients can share this fact sheet with their support systems.
Melanoma is one of the fastest growing cancers, but it can be prevented. Patients can use these tips to decrease the risk of skin cancer.
PLACE YOUR VOTE FOR THE WINNER OF THE READERS' FAVORITE CATEGORY
CLICK HERE to participate
Ann J. Brady, MSN, RN-BC
Jia Conway, DNP, FNP-BC, AOCNP, NP-C
Michele M. Farrington, BSN, RN, CPHON
Donald R. Fleming, MD
Arati Jairam-Thodla, MSN, CNP
Karen MacDonald, RN, BSN, CPON
Marlene McGuire, RN, MA, ANP-C
Kerstin L. McSteen, BSN, MSN, ACHPN, CNS-BC
Helen H. Miller, LCSW, ACSW
Maribel Pereiras, PharmD, BCPS, BCOP
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|